Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Not Just J&J’s Problem: The Evolving Talc Litigation Landscape

This article is powered by The Rose Sheet

Executive Summary

Legal experts see cosmetic talc suits flaring along two tracks – either alleging the carcinogenicity of talc itself or linking cancer cases to asbestos-tainted talc sources. At least one attorney sees the latter as a potentially bigger threat to the cosmetics industry with the traditional pool of asbestos defendants drying up.

You may also be interested in...



Colgate's Ups, Downs In Bicoastal Fight Against Talc Mesothelioma Suits

Johnson & Johnson isn't the only personal-care giant embroiled in litigation over talcum powders' alleged cancer links. Colgate-Palmolive is battling suits in Pennsylvania and California alleging that plaintiffs' mesothelioma was caused by asbestos-tainted talc in Cashmere Bouquet products sold by the firm until the mid-1990s.

J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame

What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm may begin thinning out following a June mistrial and now the reversal of an earlier $72m verdict against the company, both due to jurisdictional issues dictated by a recent Supreme Court ruling.

J&J Slammed With Costliest Talc Verdict Yet; California Plaintiff Awarded $417M

California could emerge as the new hub for talc litigation following a Los Angeles jury verdict awarding $417m in damages to a terminally ill plaintiff who linked her ovarian cancer to longtime use of J&J's talcum powder products.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108957

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel